Article
Endocytic Pathways Used by Andes Virus to Enter Primary Human Lung Endothelial Cells
25 Oct 2016
Abstract excerpt
Andes virus (ANDV) is the major cause of hantavirus pulmonary syndrome (HPS) in South America. Despite a high fatality rate (up to 40%), no vaccines or antiviral therapies are approved to treat ANDV infection. To understand the role of endocytic pathways in ANDV infection, we used 3 complementary approaches to identify cellular factors required for ANDV entry into human lung microvascular endothelial cells. We...
Topics
Join the communities discussing this publication.
